DADC
KDNY

D.A. Davidson & Co’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

D.A. Davidson & Co’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-60
Closed -$3K – 2090
2017
Q2 		$3K Hold
60
– – ﹤0.01% 2277
2017
Q1 		$3K Hold
60
– – ﹤0.01% 2250
2016
Q4 		$3K Hold
60
– – ﹤0.01% 2333
2016
Q3 		$3K Buy
+60
New +$4.24K ﹤0.01% 2267

Other funds holding KDNY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.A. Davidson & Co's KDNY Position: Q3 2017 in Review

D.A. Davidson & Co sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2017, closing a stake of 60 shares — an estimated $3K sold.

D.A. Davidson & Co first reported a position in KDNY in Q3 2016 and held it in 4 quarters. The position peaked at $3K in Q2 2017. 90 funds tracked by Wall St. Rank hold KDNY as of Q3 2017.

  • D.A. Davidson & Co reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 60 Chinook Therapeutics, Inc. Common Stock shares in Q3 2017, an estimated $3K.
  • D.A. Davidson & Co first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2016 and held it in 4 quarters.
  • D.A. Davidson & Co's Chinook Therapeutics, Inc. Common Stock position peaked at $3K in Q2 2017.
  • 90 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.